MedTrace Logo

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

NCT00946621 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioavailability study of Ramipril 10 mg capsules under non-fasting conditions.

Conditions

Interventions

DRUG

Ramipril 10 mg Capsule (Sandoz)

DRUG

Altace (Ramipril) 10 mg Capsule (Aventis Pharmaceutical)

Sponsors & Collaborators

Principal Investigators

  • Steven Herrmann, M.D., PhD · Cetero Research, San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2004-11-30
Completion
2004-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946621 on ClinicalTrials.gov